Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Cloratadd-D vs Allegra-D in Perennial Allergic Rhinitis
NCT01228630Phase 3Completed
- Sponsor
- Azidus Laboratories Limited
- Start
- Aug 2011
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of loratadine + pseudoephedrine in perennial allergic rhinitis (PAR), sponsored by Azidus Laboratories Limited. Started Aug 2011; status: completed.
02
Drugs
loratadine + pseudoephedrine
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT01228630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01228630.